APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Niraparib Preparations

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Niraparib Preparations Industry Growth and Trends Forecast to 2032

Report ID 174017160128 December 202577 pages

Choose your research edition.

Industry ResearchNiraparib Preparations Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Niraparib Preparations Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Niraparib Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Niraparib Preparations Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Niraparib Preparations Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Niraparib Preparations market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Niraparib Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Niraparib Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Niraparib Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Niraparib Preparations include Zai Lab, Takeda Pharmaceutical, Janssen Biotech and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Niraparib Preparations market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Niraparib Preparations market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Niraparib Preparations market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Niraparib Preparations.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Niraparib Preparations market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Niraparib Preparations Market by Company

Zai Lab

Takeda Pharmaceutical

Janssen Biotech

GSK

Niraparib Preparations Segment by Type

Single Drug

Combination Preparation

Niraparib Preparations Segment by Application

Ovarian Cancer

Prostate Cancer

Primary Peritoneal Cancer

Other

Niraparib Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Niraparib Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Niraparib Preparations manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Niraparib Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Drug Table 2. Major Company of Combination Preparation Table 3. Global Niraparib Preparations Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 5. Global Niraparib Preparations Sales Market Share in Volume by Type (2021-2026) Table 6. Global Niraparib Preparations Sales by Type (2021-2026) & (US$ Million) Table 7. Global Niraparib Preparations Sales Market Share in Value by Type (2021-2026) Table 8. Global Niraparib Preparations Price by Type (2021-2026) & (US$/Unit) Table 9. Global Niraparib Preparations Sales by Type (2027-2032) & (K Units) Table 10. Global Niraparib Preparations Sales Market Share in Volume by Type (2027-2032) Table 11. Global Niraparib Preparations Sales by Type (2027-2032) & (US$ Million) Table 12. Global Niraparib Preparations Sales Market Share in Value by Type (2027-2032) Table 13. Global Niraparib Preparations Price by Type (2027-2032) & (US$/Unit) Table 14. North America Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 15. North America Niraparib Preparations Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 17. Europe Niraparib Preparations Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Niraparib Preparations Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 21. Latin America Niraparib Preparations Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Niraparib Preparations Sales by Type (2021-2026) & (US$ Million) Table 24. Niraparib Preparations Industry Trends Table 25. Niraparib Preparations Industry Drivers Table 26. Niraparib Preparations Industry Opportunities and Challenges Table 27. Niraparib Preparations Industry Restraints Table 28. Global Niraparib Preparations Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Niraparib Preparations Revenue Market Share by Company (2021-2026) Table 30. Global Niraparib Preparations Sales by Company (2021-2026) & (K Units) Table 31. Global Niraparib Preparations Sales Share by Company (2021-2026) Table 32. Global Niraparib Preparations Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Niraparib Preparations Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Niraparib Preparations Major Company Production Sites and Headquarters Table 35. Global Niraparib Preparations Company, Product Type & Application Table 36. Global Niraparib Preparations Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Niraparib Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Niraparib Preparations Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Niraparib Preparations Sales by Region (2021-2026) & (K Units) Table 41. Global Niraparib Preparations Sales Market Share in Volume by Region (2021-2026) Table 42. Global Niraparib Preparations Sales by Region (2021-2026) & (US$ Million) Table 43. Global Niraparib Preparations Sales Market Share in Value by Region (2021-2026) Table 44. Global Niraparib Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Niraparib Preparations Sales by Region (2027-2032) & (K Units) Table 46. Global Niraparib Preparations Sales Market Share in Volume by Region (2027-2032) Table 47. Global Niraparib Preparations Sales by Region (2027-2032) & (US$ Million) Table 48. Global Niraparib Preparations Sales Market Share in Value by Region (2027-2032) Table 49. Global Niraparib Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Niraparib Preparations Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 52. Global Niraparib Preparations Sales Market Share in Volume by Application (2021-2026) Table 53. Global Niraparib Preparations Sales by Application (2021-2026) & (US$ Million) Table 54. Global Niraparib Preparations Sales Market Share in Value by Application (2021-2026) Table 55. Global Niraparib Preparations Price by Application (2021-2026) & (US$/Unit) Table 56. Global Niraparib Preparations Sales by Application (2027-2032) & (K Units) Table 57. Global Niraparib Preparations Sales Market Share in Volume by Application (2027-2032) Table 58. Global Niraparib Preparations Sales by Application (2027-2032) & (US$ Million) Table 59. Global Niraparib Preparations Sales Market Share in Value by Application (2027-2032) Table 60. Global Niraparib Preparations Price by Application (2027-2032) & (US$/Unit) Table 61. North America Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 62. North America Niraparib Preparations Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 64. Europe Niraparib Preparations Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Niraparib Preparations Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 68. Latin America Niraparib Preparations Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Niraparib Preparations Sales by Application (2021-2026) & (US$ Million) Table 71. Zai Lab Company Information Table 72. Zai Lab Business Overview Table 73. Zai Lab Niraparib Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zai Lab Niraparib Preparations Product Portfolio Table 75. Zai Lab Recent Development Table 76. Takeda Pharmaceutical Company Information Table 77. Takeda Pharmaceutical Business Overview Table 78. Takeda Pharmaceutical Niraparib Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Takeda Pharmaceutical Niraparib Preparations Product Portfolio Table 80. Takeda Pharmaceutical Recent Development Table 81. Janssen Biotech Company Information Table 82. Janssen Biotech Business Overview Table 83. Janssen Biotech Niraparib Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Janssen Biotech Niraparib Preparations Product Portfolio Table 85. Janssen Biotech Recent Development Table 86. GSK Company Information Table 87. GSK Business Overview Table 88. GSK Niraparib Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GSK Niraparib Preparations Product Portfolio Table 90. GSK Recent Development Table 91. North America Niraparib Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 93. North America Niraparib Preparations Sales Market Share by Country (2021-2026) Table 94. North America Niraparib Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Niraparib Preparations Sales Market Share Forecast by Country (2027-2032) Table 96. North America Niraparib Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Niraparib Preparations Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Niraparib Preparations Market Share by Country (2021-2026) Table 99. North America Niraparib Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Niraparib Preparations Market Share Forecast by Country (2027-2032) Table 101. Europe Niraparib Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 103. Europe Niraparib Preparations Sales Market Share by Country (2021-2026) Table 104. Europe Niraparib Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Niraparib Preparations Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Niraparib Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Niraparib Preparations Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Niraparib Preparations Market Share by Country (2021-2026) Table 109. Europe Niraparib Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Niraparib Preparations Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Niraparib Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Niraparib Preparations Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Niraparib Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Niraparib Preparations Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Niraparib Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Niraparib Preparations Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Niraparib Preparations Market Share by Country (2021-2026) Table 119. Asia-Pacific Niraparib Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Niraparib Preparations Market Share Forecast by Country (2027-2032) Table 121. Latin America Niraparib Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 123. Latin America Niraparib Preparations Sales Market Share by Country (2021-2026) Table 124. Latin America Niraparib Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Niraparib Preparations Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Niraparib Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Niraparib Preparations Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Niraparib Preparations Market Share by Country (2021-2026) Table 129. Latin America Niraparib Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Niraparib Preparations Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Niraparib Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Niraparib Preparations Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Niraparib Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Niraparib Preparations Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Niraparib Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Niraparib Preparations Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Niraparib Preparations Market Share by Country (2021-2026) Table 139. Middle East and Africa Niraparib Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Niraparib Preparations Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Niraparib Preparations Distributors List Table 144. Niraparib Preparations Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Niraparib Preparations Image Figure 2. Global Niraparib Preparations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Niraparib Preparations Market Size (2021-2032) & (US$ Million) Figure 4. Global Niraparib Preparations Sales (2021-2032) & (K Units) Figure 5. Single Drug Image Figure 6. Global Single Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Preparation Image Figure 8. Global Combination Preparation Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Niraparib Preparations Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Niraparib Preparations Market Share by Type 2025 VS 2032 Figure 11. North America Niraparib Preparations Sales Market Share in Volume by Type in 2025 Figure 12. North America Niraparib Preparations Sales Market Share in Value by Type in 2025 Figure 13. Europe Niraparib Preparations Sales Market Share in Volume by Type in 2025 Figure 14. Europe Niraparib Preparations Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Niraparib Preparations Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Niraparib Preparations Sales Market Share in Value by Type in 2025 Figure 17. Latin America Niraparib Preparations Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Niraparib Preparations Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Niraparib Preparations Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Niraparib Preparations Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Niraparib Preparations Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Ovarian Cancer Image Figure 24. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Prostate Cancer Image Figure 26. Global Prostate Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Primary Peritoneal Cancer Image Figure 28. Global Primary Peritoneal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Niraparib Preparations Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Niraparib Preparations Market Share by Application 2025 VS 2032 Figure 33. North America Niraparib Preparations Sales Market Share in Volume by Application in 2025 Figure 34. North America Niraparib Preparations Sales Market Share in Value by Application in 2025 Figure 35. Europe Niraparib Preparations Sales Market Share in Volume by Application in 2025 Figure 36. Europe Niraparib Preparations Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Niraparib Preparations Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Niraparib Preparations Sales Market Share in Value by Application in 2025 Figure 39. Latin America Niraparib Preparations Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Niraparib Preparations Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Niraparib Preparations Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Niraparib Preparations Sales Market Share in Value by Application in 2025 Figure 43. North America Niraparib Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Niraparib Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Niraparib Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Niraparib Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Niraparib Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Niraparib Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Niraparib Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Niraparib Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Niraparib Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Niraparib Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Niraparib Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Niraparib Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Niraparib Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Niraparib Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Niraparib Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Niraparib Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Niraparib Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Niraparib Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Niraparib Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Niraparib Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Niraparib Preparations Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Niraparib Preparations Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • Ovarian Cancer
  • Prostate Cancer
  • Primary Peritoneal Cancer
  • Other
Companies covered
  • Zai Lab
  • Takeda Pharmaceutical
  • Janssen Biotech
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Niraparib Preparations Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Niraparib Preparations Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Niraparib Preparations Market by Type
  6. 1.3.1 Single Drug
  7. 1.3.2 Combination Preparation
  8. 1.4 Global Niraparib Preparations Market Size by Type
  9. 1.4.1 Global Niraparib Preparations Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Niraparib Preparations Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Niraparib Preparations Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Niraparib Preparations Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Niraparib Preparations Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Niraparib Preparations Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Niraparib Preparations Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Niraparib Preparations Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Niraparib Preparations Industry Trends
  2. 2.2 Niraparib Preparations Industry Drivers
  3. 2.3 Niraparib Preparations Industry Opportunities and Challenges
  4. 2.4 Niraparib Preparations Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Niraparib Preparations Revenue (2021-2026)
  2. 3.2 Global Top Players by Niraparib Preparations Sales (2021-2026)
  3. 3.3 Global Top Players by Niraparib Preparations Price (2021-2026)
  4. 3.4 Global Niraparib Preparations Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Niraparib Preparations Major Company Production Sites & Headquarters
  6. 3.6 Global Niraparib Preparations Company, Product Type & Application
  7. 3.7 Global Niraparib Preparations Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Niraparib Preparations Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Niraparib Preparations Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Niraparib Preparations Tier 1, Tier 2, and Tier 3
4 Niraparib Preparations Regional Status and Outlook
  1. 4.1 Global Niraparib Preparations Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Niraparib Preparations Historic Market Size by Region
  3. 4.2.1 Global Niraparib Preparations Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Niraparib Preparations Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Niraparib Preparations Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Niraparib Preparations Forecasted Market Size by Region
  7. 4.3.1 Global Niraparib Preparations Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Niraparib Preparations Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Niraparib Preparations Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Niraparib Preparations by Application
  1. 5.1 Niraparib Preparations Market by Application
  2. 5.1.1 Ovarian Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Primary Peritoneal Cancer
  5. 5.1.4 Other
  6. 5.2 Global Niraparib Preparations Market Size by Application
  7. 5.2.1 Global Niraparib Preparations Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Niraparib Preparations Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Niraparib Preparations Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Niraparib Preparations Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Niraparib Preparations Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Niraparib Preparations Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Niraparib Preparations Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Niraparib Preparations Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zai Lab
  2. 6.1.1 Zai Lab Company Information
  3. 6.1.2 Zai Lab Business Overview
  4. 6.1.3 Zai Lab Niraparib Preparations Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zai Lab Niraparib Preparations Product Portfolio
  6. 6.1.5 Zai Lab Recent Developments
  7. 6.2 Takeda Pharmaceutical
  8. 6.2.1 Takeda Pharmaceutical Company Information
  9. 6.2.2 Takeda Pharmaceutical Business Overview
  10. 6.2.3 Takeda Pharmaceutical Niraparib Preparations Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Pharmaceutical Niraparib Preparations Product Portfolio
  12. 6.2.5 Takeda Pharmaceutical Recent Developments
  13. 6.3 Janssen Biotech
  14. 6.3.1 Janssen Biotech Company Information
  15. 6.3.2 Janssen Biotech Business Overview
  16. 6.3.3 Janssen Biotech Niraparib Preparations Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Janssen Biotech Niraparib Preparations Product Portfolio
  18. 6.3.5 Janssen Biotech Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Niraparib Preparations Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GSK Niraparib Preparations Product Portfolio
  24. 6.4.5 GSK Recent Developments
7 North America by Country
  1. 7.1 North America Niraparib Preparations Sales by Country
  2. 7.1.1 North America Niraparib Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Niraparib Preparations Sales by Country (2021-2026)
  4. 7.1.3 North America Niraparib Preparations Sales Forecast by Country (2027-2032)
  5. 7.2 North America Niraparib Preparations Market Size by Country
  6. 7.2.1 North America Niraparib Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Niraparib Preparations Market Size by Country (2021-2026)
  8. 7.2.3 North America Niraparib Preparations Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Niraparib Preparations Sales by Country
  2. 8.1.1 Europe Niraparib Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Niraparib Preparations Sales by Country (2021-2026)
  4. 8.1.3 Europe Niraparib Preparations Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Niraparib Preparations Market Size by Country
  6. 8.2.1 Europe Niraparib Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Niraparib Preparations Market Size by Country (2021-2026)
  8. 8.2.3 Europe Niraparib Preparations Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Niraparib Preparations Sales by Country
  2. 9.1.1 Asia-Pacific Niraparib Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Niraparib Preparations Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Niraparib Preparations Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Niraparib Preparations Market Size by Country
  6. 9.2.1 Asia-Pacific Niraparib Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Niraparib Preparations Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Niraparib Preparations Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Niraparib Preparations Sales by Country
  2. 10.1.1 South America Niraparib Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Niraparib Preparations Sales by Country (2021-2026)
  4. 10.1.3 South America Niraparib Preparations Sales Forecast by Country (2027-2032)
  5. 10.2 South America Niraparib Preparations Market Size by Country
  6. 10.2.1 South America Niraparib Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Niraparib Preparations Market Size by Country (2021-2026)
  8. 10.2.3 South America Niraparib Preparations Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Niraparib Preparations Sales by Country
  2. 11.1.1 Middle East and Africa Niraparib Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Niraparib Preparations Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Niraparib Preparations Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Niraparib Preparations Market Size by Country
  6. 11.2.1 Middle East and Africa Niraparib Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Niraparib Preparations Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Niraparib Preparations Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Niraparib Preparations Value Chain Analysis
  2. 12.1.1 Niraparib Preparations Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Niraparib Preparations Production Mode & Process
  7. 12.2 Niraparib Preparations Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Niraparib Preparations Distributors
  10. 12.2.3 Niraparib Preparations Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst